By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Catabasis Pharmaceuticals, Inc. 

161 First Street, Suite 1A

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-349-1971 Fax: 617-273-2637


SEARCH JOBS


Industry
Pharmaceutical






Company News
Catabasis Pharmaceuticals, Inc. To Present At Parent Project Muscular Dystrophy (PPMD) Annual Connect Conference And New Directions In Biology And Disease Of Skeletal Muscle Conference 6/24/2014 8:45:50 AM
Catabasis Pharmaceuticals, Inc. Announces Issuance Of Three New US Patents For CAT-1000 Series 6/11/2014 8:24:34 AM
Catabasis Pharmaceuticals, Inc. Demonstrates CAT-2003 Lowers Fed And Fasting Triglycerides In Studies Presented At Lipid Conferences 5/5/2014 6:41:30 AM
Catabasis Pharmaceuticals, Inc. Describes Modulation Of SREBP As Mechanism For CAT-2003 5/1/2014 2:06:20 PM
Catabasis Pharmaceuticals, Inc. To Present CAT-2003 Data At Upcoming Lipid Conferences 4/25/2014 7:04:30 AM
Catabasis Pharmaceuticals, Inc. To Present CAT-2003 Data At The American College of Cardiology’s 63rd Annual Scientific Session 3/31/2014 6:44:41 AM
Catabasis Pharmaceuticals, Inc. To Present Data On CAT-1004 At The Muscular Dystrophy Association's 2014 Clinical Conference 3/14/2014 6:38:04 AM
Catabasis Pharmaceuticals, Inc. Names Andrew Nichols, Ph.D., Vice President Of Research 2/26/2014 6:38:09 AM
Catabasis Pharmaceuticals, Inc. Announces Appointment Of Kenneth M. Bate As Independent Director 2/4/2014 7:19:55 AM
Catabasis Pharmaceuticals, Inc. To Present At 32nd Annual J.P. Morgan Healthcare Conference 1/8/2014 7:13:46 AM
1234
//-->